Suppr超能文献

理解临床试验中的优效性、非劣效性和等效性。

Understanding Superiority, Noninferiority, and Equivalence for Clinical Trials.

作者信息

Kishore Kamal, Mahajan Rahul

机构信息

Department of Biostatistics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Department of Dermatology, Venereology, and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

出版信息

Indian Dermatol Online J. 2020 Sep 19;11(6):890-894. doi: 10.4103/idoj.IDOJ_130_20. eCollection 2020 Nov-Dec.

Abstract

Randomized control trialsare the gold standard for testing the efficacy of new interventions. Historically, superiority trials were methods of choice as reference (standard) interventions were not established for many disease conditions. However currently, reference interventions are available for most of adverse conditions. Despite this, many investigators are using superiority trials in comparison to more suitable noninferiority and equivalence trials. The application of noninferiority and equivalence trials is on the rise, but by and large, these trials are poorly understood, ill-conceived, inappropriately analyzed, and reported and misinterpreted.

摘要

随机对照试验是测试新干预措施疗效的金标准。从历史上看,优效性试验是首选方法,因为许多疾病状况尚未确立参考(标准)干预措施。然而,目前大多数不良状况都有了参考干预措施。尽管如此,与更合适的非劣效性试验和等效性试验相比,许多研究者仍在使用优效性试验。非劣效性试验和等效性试验的应用正在增加,但总体而言,这些试验仍未得到充分理解、构思不当、分析和报告有误且被误解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1685/7734976/401f9c9860b0/IDOJ-11-890-g007.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验